Dr Sheuli Porkess is an experienced industry expert in medicines development, medical affairs and research policy within the UK and internationally, across multiple therapy areas. Sheuli has held Medical Director roles in industry and is the former Director of Research, Medical and Innovation at the ABPI, leading on policy work in innovation, clinical research, COVID, Brexit, bioethics, appropriate prescribing and patient involvement. As well as being an OVID Associate, Sheuli is the Vice-President Elect for the Faculty of Pharmaceutical Medicine and holds a number of other roles including membership of the Scientific Advisory Boards for C2-Ai, a healthcare analytics company, and the AGILE pandemic clinical trial platform and the UK Pandemic Ethics Accelerator, as well as being a member of the NIHR AI for Multiple Long-term conditions (AIM) Programme Steering Group.